URSOBLAZE 300

Introduction

URSOBLAZE 300 is a prescription medicine containing Ursodeoxycholic Acid (UDCA) 300 mg, a naturally occurring hydrophilic bile acid that has been extensively studied for the management of cholestatic liver diseases and cholesterol gallstones. It helps improve bile flow, reduces the cholesterol content of bile, and protects liver cells from the harmful effects of toxic bile acids.

URSOBLAZE 300 is widely prescribed in patients with hepatobiliary disorders, particularly Primary Biliary Cholangitis (PBC) and selected cases of cholesterol gallstones where medical dissolution therapy is appropriate. By improving bile composition and promoting normal bile flow, it supports liver function and helps reduce bile stasis associated with cholestatic liver disorders.

When prescribed appropriately, URSOBLAZE 300 contributes to improved hepatobiliary function and supports long-term management of selected liver and biliary diseases.

Uses of URSOBLAZE 300

URSOBLAZE 300 is indicated for the treatment of hepatobiliary disorders where Ursodeoxycholic Acid therapy is clinically appropriate.

It may be prescribed for:

1. Cholesterol gallstones suitable for dissolution therapy
2. Primary Biliary Cholangitis (PBC)
3. Cholestatic liver diseases
4. Disorders associated with impaired bile flow (cholestasis)
5. Selected chronic hepatobiliary disorders as determined by the treating physician

Note: URSOBLAZE 300 is effective for cholesterol gallstones and is not indicated for calcified or pigment gallstones.

Benefits of URSOBLAZE 300

URSOBLAZE 300 contains Ursodeoxycholic Acid, one of the most extensively studied bile acids for the management of cholestatic liver disorders.

Scientific benefits include:

1. Improves bile flow and reduces cholestasis.
2. Reduces cholesterol saturation of bile, promoting gradual dissolution of selected cholesterol gallstones.
3. Protects liver cells and bile duct epithelial cells from the toxic effects of hydrophobic bile acids.
4. Improves liver biochemical parameters, including serum alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), and bilirubin levels in appropriate patients.
5. Slows disease progression and improves transplant-free survival in patients with Primary Biliary Cholangitis (PBC) when used as standard-of-care therapy.
6. Supports healthy bile composition and hepatobiliary function.
7. Sustained-release formulation provides prolonged therapeutic exposure and convenient dosing.

How URSOBLAZE 300 Works

URSOBLAZE 300 works through multiple complementary mechanisms that improve bile composition and protect the liver.

After absorption, Ursodeoxycholic Acid becomes incorporated into the bile acid pool, replacing more toxic hydrophobic bile acids with a less toxic, hydrophilic bile acid. This helps reduce bile acid-induced injury to hepatocytes and bile duct cells.

It also:

1. Reduces cholesterol secretion into bile.
2. Decreases intestinal absorption of cholesterol.
3. Improves bile flow from the liver into the intestine.
4. Reduces cholesterol supersaturation of bile, promoting gradual dissolution of susceptible cholesterol gallstones.
5. Helps protect liver cells from inflammation and cholestatic injury.

These mechanisms contribute to improved liver function, enhanced bile flow, and better management of cholestatic hepatobiliary disorders.

Dosage & Administration

URSOBLAZE 300 should be taken only under the supervision of a qualified healthcare professional.

General Adult Dosage

1. The dosage should be individualized according to the patient's indication, body weight, and clinical response.
2. The tablet should be taken with or after meals, or as directed by the treating physician.
3. Swallow the tablet whole with water. Do not crush or chew unless advised.
4. Long-term therapy may be required depending on the underlying liver or biliary condition.
5. Periodic monitoring of liver function tests and clinical response is recommended during treatment.

Possible Side Effects

Like all medicines, URSOBLAZE 300 may cause side effects, although many patients tolerate treatment well.

Commonly reported side effects include:

1. Diarrhea
2. Nausea
3. Abdominal discomfort
4. Indigestion
5. Mild abdominal pain
6. Headache
7. Skin rash (uncommon)

Patients should consult their healthcare provider if symptoms persist, worsen, or if new symptoms develop during treatment.

Contraindications & Precautions

URSOBLAZE 300 should not be used in patients with:

1. Known hypersensitivity to Ursodeoxycholic Acid or any component of the formulation.
2. Complete biliary obstruction.
3. Acute inflammation of the gallbladder or biliary tract.
4. Calcified (radiopaque) gallstones.
5. Non-functioning gallbladder.
6. Frequent episodes of biliary colic.

Important Precautions

URSOBLAZE 300 should be used with caution in patients with:

1. Hepatic impairment requiring close clinical monitoring.
2. Chronic gallbladder disease.
3. Pregnancy or breastfeeding, only if considered appropriate by the treating physician.
4. Patients receiving bile acid-binding resins (e.g., cholestyramine, colestipol), aluminium-containing antacids, or certain lipid-lowering medicines, as these may reduce the absorption or effectiveness of Ursodeoxycholic Acid.

Patients should inform their healthcare provider about all prescription medicines, over-the-counter medicines, and herbal supplements before starting URSOBLAZE 300.

Regular monitoring of liver function and clinical response is recommended, particularly during long-term therapy.

Disclaimer

The information provided on this page is intended for educational purposes only and should not replace professional medical advice, diagnosis, or treatment. URSOBLAZE 300 is a prescription medicine and should be used only under the supervision of a qualified healthcare professional. Patients should always follow their physician's advice regarding dosage, duration of treatment, and monitoring. Clinical decisions should be based on the patient's medical condition, appropriate diagnostic evaluation, and current evidence-based hepatology guidelines.